CIK 0001822791 · Non-accelerated filer<br>Smaller reporting company
Clene Inc.
Sign in to watch- Ticker
- CLNN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 852828339
- Phone
- 801-676-9695
- Business address
- 6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT, 84121
- Former names
- Chelsea Worldwide Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-14 | Jacobovitz Shalom Director | Grant or award | +20,838 | 20,838 | ||
| 2021-07-14 | Mosca Alison Director | Grant or award | +2,083 | 2,083 | ||
| 2021-07-14 | Stevens John Henry Director | Grant or award | +14,378 | 14,378 | ||
| 2021-07-14 | WILCOX REED N Director | Grant or award | +27,784 | 27,784 | ||
| 2021-06-30 | Glanzman Robert Chief Medical Officer | Grant or award | +15,281 | 15,281 | ||
| 2021-06-30 | Mortenson Mark Chief Science Officer | Grant or award | +50,082 | 50,082 | ||
| 2021-06-30 | Etherington Robert Dee Chief Executive Officer | Grant or award | +80,076 | 80,076 |
Page 22 of 22 · 427 trades